Straight from #UromigosLive 2025

A GREAT discussion on ADC use in #BladderCancer
The possibility of Combination Trials, seeing the trade off between Toxicity and the Long Term Benefit

Complete Video Here x.com/Uromigos/sta...

Dear Colleagues in #ESMO25
Our Collaborators at @mirrorsmed would like to Invite you to Join The Global Forum on GU Oncology info here👉https://gu-global-forum.org

December 3-6, 2025 in Lisbon🇵🇹or ONLINE as this is a HYBRID meeting.

OncoAlert 🚨will be Live from Lisbon covering this Great meeting

Join us for a discussion on rPFS as a surrogate for OS in mHSPC #ProstateCancer
Available now 👉 mirrorsmed.org/m2p-rpfs-sur...

What does it mean for clinical practice? How should it guide treatment decisions?

📺 Join Neal Shore, MD & Alicia Morgans, MD

Join Vérane Achard and Bertrand Timbal for this Manuscript2Practice series on postoperative #ProstateCancer recurrence 👉 mirrorsmed.org/m2p-postoper...

brought to you by our collaborators at Mirrors of Medicine.

Our Collaborators at @mirrorsofmedicine.bsky.social would like to Invite you to Join The Global Forum on GU Oncology info here👉 gu-global-forum.org

December 3-6, 2025 in Lisbon🇵🇹or ONLINE as this is a HYBRID meeting.

OncoAlert 🚨Will be live on location

You are warmly invited to join a live, free interactive webinar on November 4, 2025, at 18:00 CET REGISTER👉 us02web.zoom.us/webinar/regi...

Fred Saad and Marc-Oliver Grimm will lead an engaging case-based discussion on triplet therapy in metastatic hormone-sensitive prostate cancer (mHSPC).

Colleagues, the Complete #ESMO25 OncoAlert Newsletter is coming Oct 27‼️ GET IT HERE👉 oncoalert.m-pages.com/nhMpwe/oncoa...

50 of our PICKS of TOP Trials out of Berlin 🇩🇪
@elisaagostinetto.bsky.social @elisabettabonzano.bsky.social @erikahamilton9.bsky.social @maryamlustberg.bsky.social